Growth Metrics

Journey Medical (DERM) Raw Materials (2021)

Journey Medical filings provide 1 years of Raw Materials readings, the most recent being $5.6 million for Q4 2021.

  • On a quarterly basis, Raw Materials changed N/A to $5.6 million in Q4 2021 year-over-year; TTM through Dec 2021 was $5.6 million, a N/A change, with the full-year FY2021 number at $5.6 million, changed N/A from a year prior.
  • Raw Materials hit $5.6 million in Q4 2021 for Journey Medical, up from $5.5 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $5.6 million in Q4 2021 to a low of $5.5 million in Q3 2021.